Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a recent market intelligence study, Data Bridge Market Research extensively examined the Statin Market. The findings of this research have been presented in a newly published report that boasts an attractive layout, incorporating visually captivating tables, graphs, charts, and figures. By seamlessly integrating...
StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research report report published on Thursday morning. The firm issued a buy rating on the stock. Trinity Biotech Stock Performance NASDAQ:TRIB opened at $0.98 on Thursday. The stock has a fifty day moving average price of $0.96 and a 200-day moving […]
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a report issued on Wednesday morning. The firm issued a buy rating on the stock. Trinity Biotech Stock Performance NASDAQ:TRIB opened at $1.00 on Wednesday. The company has a market cap of $38.11 million, a PE ratio of -1.06 and a beta […]
The global point-of-care market is expected to reach $75.5 billion by 2027 from an estimated $45.4 billion in 2022, at a CAGR of 10.7% from 2022 to 2027.